Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Conventional implants were employed by orthopaedic surgeons to repair the inner fixation for years. These implants have needed heaps of development over the decades. Irrespective it’s wide spread use, there are some problems allied with conventional implants which include the stress shielding, breakage, reaction of the material, interference with the imaging devices and restricted growth in young patients. Recently, many bioresorbable implants have been made available as a feasible alternative to various indications. Bioresorbable implants are implants made of a resorbable material which degrade and get eliminated from the body in a period of time when implanted in patients. In the early stages of bone healing, bioabsorbable implants preserve fixation. Over time, the implant gradually decomposes, and the stresses are steadily transferred to the healing tissue.
There are many factors which are driving the bioresorbable implants market like growing cases of chronic diseases, increasing incidences of road accidents growing disposable incomes and high level of healthcare and increasing geriatric population worldwide. According to the United Nations, 2017, nearly 13 % of the global population comprised of people aged 60 plus years. Moreover, the capability of bioresorbable implants to dissolve inside the body without the restraint of surgical removal is motivating the acceptance of such implants in healthcare. Bioresorbable implants have started to gain traction due to its various applications such as orthopedic implants. Conversaly, the high cost of bioresorbable implants and time-consuming approval for bioresorbable implants, is likely to restraint the market progress.
The report analyses the Bioresorbable Implants Market based on type, application and geography.
The various types of bioresorbable implants studied in this verticle metallic and polymer implants. The polymer segment consist of PLLA- Poly L-lactide, PLGA- Polylactic-co-glycolic acid, PLA- Polylactic Acid and PGA- Polyglycolic Acid. Bioresorbable polymer implants are rapidly growing alternatives to traditional implants in many applications. PLA is derived from renewable resources, such as corn starch or sugarcanes. Currently, there are several bioresorbable stent designs commercially available in the market of which Absorb is the most developed and was the first to become commercially available.
Bioresorabable implants finds application in Orthopedic, Cardiovascular etc. With the growing incidence of orthopaedic and cardiovascular diseases, there continues to be great interest in the development of novel technologies including bioresorbable implants to further improve the effective clinical performance of contemporary treatment devices. The capability of bioresorbable implants to dissolve inside the body without the constraint of surgical removal is driving the acceptance of such implants in in various applications
The major end user of the bioresobable implants are Hospitals, Ambulatory surgical centers etc.
The global study of bioresorbable implants vertical conducted to estimate and forecast revenue across the countries of key regions of North America, Europe, APAC and rest of the world regions. North America held the highest market share in the bioresorbable implants market owing to the presence of sophisticated healthcare infrastructure, high prevalence of several chronic diseases, increasing cases of heart disorders, and rising investments in healthcare. The availability of medical reimbursements is continuously increasing among mature markets such as the US which will further develop the growth of the market.
Asia Pacific is expected to witness lucrative CAGR over a forecast 2020-2025 due to the presence of high unmet medical needs, coupled with rapidly rising healthcare R&D investments and growing medical expenditures in emerging economies, such as India and China. Moreover, supportive government initiatives pertaining to increasing investments by manufacturers and high untapped market opportunities are the important factors attributed to the high growth of the market in this region.
Some of the major players opening in this region include Bioretec Ltd., CONMED Corporation, Depuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew Plc., and Boston Scientific Corporation among others.
The report analyses the Bioresorbable Implants Market based on type, application and geography. The various types of bioresorbable implants studied in this verticle metallic and polymer implants. The polymer segment consist of PLLA- Poly L-lactide, PLGA- Polylactic-co-glycolic acid, PLA- Polylactic Acid and PGA- Polyglycolic Acid. Bioresorabable implants finds application in Orthopedic, Cardiovascular etc.
The global study of bioresorbable implants vertical conducted to estimate and forecast revenue across the countries of key regions of North America, Europe, APAC and rest of the world regions.
Some of the major players opening in this region include Bioretec Ltd., CONMED Corporation, Depuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew Plc., and Boston Scientific Corporation among others.
Scientific Corporation, Merit Medical Systems, Inc., W.L. Gore & Associates, Inc., Abbott Laboratories among others.
Why to Buy This Report:
